about
Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current statusRenaissance of (18)F-FDG positron emission tomography in the imaging of pheochromocytoma/paraganglioma.Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene.A case of (123)I-MIBG scintigram-negative functioning pheochromocytoma: immunohistochemical and molecular analysis with review of literatureMalignant head and neck paragangliomas: is there an optimal treatment strategy?New imaging approaches to phaeochromocytomas and paragangliomas.Detecting pheochromocytoma: defining the most sensitive test.Disseminated malignant phaeochromocytoma: localisation with iodine-131-labelled meta-iodobenzylguanidine.Targeted radiotherapy for neuroblastomaPheochromocytoma and paraganglioma: current functional and future molecular imaging.Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology GroupFalse-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease.A practical, automated synthesis of meta-[(18)F]fluorobenzylguanidine for clinical use.Iodine-131 meta-iodobezylguanidine single photon emission computed tomography/computerized tomography in diagnosis of neuro-endocrine tumors.Radiolabeled phenethylguanidines: novel imaging agents for cardiac sympathetic neurons and adrenergic tumors.ACP Broadsheet No 127: April 1991. Measurement of catecholamines and their metabolites in urineRadiopharmaceuticals drug interactions: a critical review.Functional paraganglioma¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.Diagnostic problems in pheochromocytoma.Impact of medications on mIBG uptake, with specific attention to the heart: Comprehensive review of the literature.The use of an investigational radiopharmaceutical in neuroblastoma: a nursing perspective.Radiochemical diagnosis of adrenal disease.'Elephant man' with severe hypertension.Tetracyclic Antidepressant Causing Altered Biodistribution of MIBG.Catecholamine measurements in clinical medicine.Validation of post-induction Curie scores in high risk neuroblastoma. A Children's Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1.Phaeochromocytoma: diagnosis and managementClinical experiences in the treatment of neuroblastoma with 131I-metaiodobenzylguanidine.A clinical scoring system for detection of patients with pheochromocytomas.Nuclear medicine imaging in the evaluation of endocrine hypertension.Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma.Functional imaging as an aid to decision-making in metastatic paraganglioma.Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].Case report: drug interference with MIBG uptake in a patient with metastatic paraganglioma.Multiple endocrine neoplasia type 2 with malignant pheochromocytoma--long term follow-up of a case by 131I-meta-iodobenzylguanidine scintigraphy.Effectiveness of neonatal transport systems.131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma.
P2860
Q33611606-35BE65FF-9B44-496F-A006-97C709B63A58Q33652433-49C7A859-464A-4F5D-91BF-50B91493F64EQ33837098-B35C6DB7-F254-4ED3-A085-FED2F70EA9DEQ33887843-6C9359E2-44B6-4FAB-8CA2-992FBB335698Q33887850-98987E69-3A8A-4D4A-B968-BA230D79B240Q34029349-63D2E031-5517-4FBC-A59E-A762278843B3Q34208481-5D863C13-81D8-4A86-81B3-4E654E40271CQ34255457-935C7BCF-7B46-48AE-BB48-887490763466Q34478801-2C0257C4-42CB-4C71-95A5-09663B4DA9D9Q34764717-92986448-8208-469F-B119-33C8D3CBF249Q35257440-706051BC-EF02-4996-96AB-DF1945262B80Q35972320-580138A2-EA38-4394-8CF9-68A5B94404E2Q36089239-96C8718B-D14F-46F1-9374-E32CC12C48CEQ36167038-F2B7E21F-F242-4F47-9ACB-3715F307B547Q36296809-26FE2304-195B-417E-ADD9-EE6E349BBBFAQ36771833-6606EC9F-7D9B-4627-B480-54E6E64E8D96Q37059208-35397792-D2C1-44A7-859C-7469728A3BC3Q37143210-DC8A563B-798D-4901-98F5-FC6107297044Q37336629-A114B346-D52D-4F66-95F1-51FD78C8AFF2Q37597995-FBD6DCBD-0464-418C-8A0C-982BAECA39B2Q37990403-4A9CF8E4-C4AD-49C6-8F2C-33276C492E5FQ38371835-6660118A-05E9-4B07-A9EA-8277602BFDE6Q38480977-6F5B6995-818B-40B8-B051-82B2ECC19700Q38518041-AE742307-7280-47A0-8F79-F2704991AF23Q38694123-E4396C92-0834-4833-AB82-27DB5AF73836Q38705427-C728E2FF-0B2F-4A14-9DE5-0463713ABCE3Q38866551-FD0917FE-61E5-4CC2-ADC9-7B0E87370B3DQ38930546-0717F1B6-250C-467E-8B88-242C2DCD6D5BQ40050078-B96D0967-2295-4B1D-A5A4-7E3AFF79AC72Q40663679-0A695126-EB27-49B7-95D9-BD4CEB403250Q40813144-0C49C8C3-1282-4A53-965D-18C6823BF7D4Q41540083-B0CB7CAD-2D9F-445A-989F-09A678B4A488Q41839681-3C1382AE-C775-47CF-B72A-DC828061BE21Q43152142-E8B0C96D-F805-47C1-A59F-8D0E5DBCA37CQ43598279-41BCF422-83C7-40DC-AD09-E4A780674466Q43674501-37A4DD7F-D441-4889-B8E8-81AA7378221DQ44902247-41961C14-2739-466D-B916-DEECA5B0448CQ45129494-AB9FF5E2-68A7-4449-978C-3CB75AB4FB36Q46377258-EEC7AC90-8740-4DBB-AEA7-B4969B7D5CF9Q46856513-EF5D9720-2725-4AE6-859D-AA4BCE91F13F
P2860
description
1981 nî lūn-bûn
@nan
1981 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Scintigraphic localization of pheochromocytoma.
@ast
Scintigraphic localization of pheochromocytoma.
@en
Scintigraphic localization of pheochromocytoma.
@nl
type
label
Scintigraphic localization of pheochromocytoma.
@ast
Scintigraphic localization of pheochromocytoma.
@en
Scintigraphic localization of pheochromocytoma.
@nl
prefLabel
Scintigraphic localization of pheochromocytoma.
@ast
Scintigraphic localization of pheochromocytoma.
@en
Scintigraphic localization of pheochromocytoma.
@nl
P2093
P1476
Scintigraphic localization of pheochromocytoma.
@en
P2093
Beierwaltes WH
Swanson DP
Thompson NW
Wieland DM
P356
10.1056/NEJM198107023050103
P407
P577
1981-07-01T00:00:00Z